These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7922361)

  • 1. T-cell selection. Accentuating the positive.
    Parham P
    Curr Biol; 1994 May; 4(5):444-7. PubMed ID: 7922361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of T-cell activation with T-cell receptor assembly.
    Terhorst C; Exley M; Franco R; Hall C; Kang J; Mueller B; Sancho J; She J; Wileman T
    Year Immunol; 1993; 7():1-24. PubMed ID: 8372498
    [No Abstract]   [Full Text] [Related]  

  • 3. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A signal integration model of thymic selection and natural regulatory T cell commitment.
    Khailaie S; Robert PA; Toker A; Huehn J; Meyer-Hermann M
    J Immunol; 2014 Dec; 193(12):5983-96. PubMed ID: 25392533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limits to the differential avidity model of T cell selection in the thymus.
    Girao C; Hu Q; Sun J; Ashton-Rickardt PG
    J Immunol; 1997 Nov; 159(9):4205-11. PubMed ID: 9379014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-affinity peptides and T-cell selection.
    Ziegler A; Müller CA; Böckmann RA; Uchanska-Ziegler B
    Trends Immunol; 2009 Feb; 30(2):53-60. PubMed ID: 19201651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive selection through a motif in the alphabeta T cell receptor.
    Bäckström BT; Müller U; Hausmann B; Palmer E
    Science; 1998 Aug; 281(5378):835-8. PubMed ID: 9694657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.
    Natarajan K; Burstyn D; Zauderer M
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8874-8. PubMed ID: 1384036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.
    Moudgil KD; Grewal IS; Jensen PE; Sercarz EE
    J Exp Med; 1996 Feb; 183(2):535-46. PubMed ID: 8627165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recognition of MHC molecules by gamma delta T cells.
    Schild H; Chien YH
    Behring Inst Mitt; 1994 Jul; (94):113-23. PubMed ID: 7998905
    [No Abstract]   [Full Text] [Related]  

  • 16. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.
    Evavold BD; Sloan-Lancaster J; Allen PM
    Immunol Today; 1993 Dec; 14(12):602-9. PubMed ID: 8305133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45.
    Trop S; Charron J; Arguin C; Lesage S; Hugo P
    J Immunol; 2000 Sep; 165(6):3073-9. PubMed ID: 10975818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low affinity interaction of peptide-MHC complexes with T cell receptors.
    Matsui K; Boniface JJ; Reay PA; Schild H; Fazekas de St Groth B; Davis MM
    Science; 1991 Dec; 254(5039):1788-91. PubMed ID: 1763329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion.
    Barnden MJ; Heath WR; Rodda S; Carbone FR
    Eur J Immunol; 1994 Oct; 24(10):2452-6. PubMed ID: 7925574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deriving quantitative constraints on T cell selection from data on the mature T cell repertoire.
    Detours V; Mehr R; Perelson AS
    J Immunol; 2000 Jan; 164(1):121-8. PubMed ID: 10605002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.